Cosciens Biopharma Inc.

CSCIF·OTC·$1.85Share Price as of 11/2·$6MMarket Cap as of 11/2

Financials

20-FAnnual report (foreign)03/25/26 20-FAnnual report (foreign)04/09/25 20-F/AAnnual report (foreign, amended)07/17/24 20-FAnnual report (foreign)03/27/24 20-F/AAnnual report (foreign, amended)02/15/24

Disclosures

6-KForeign issuer report07/06/26 6-KForeign issuer report06/23/26 6-KForeign issuer report06/18/26 6-KForeign issuer report05/20/26 6-KForeign issuer report05/12/26

Prospectuses and Registrations

POS AMPost-effective amendment03/13/26 POS AMPost-effective amendment03/13/26 POS AMPost-effective amendment03/13/26 POS AMPost-effective amendment03/13/26 POS AMPost-effective amendment03/13/26

Proxies

No matching filings.

Ownership

SC 13D/ABeneficial ownership (amended)04/17/26 SC 13D/ABeneficial ownership (amended)06/11/25 SC 13D/ABeneficial ownership (amended)12/20/24 SC 13DBeneficial ownership09/06/24 SC 13GBeneficial ownership06/06/24

Other

15-12GCertification of termination of registration07/06/26 SC 13E3/ASC 13E3/A07/06/26 SC 13E3/ASC 13E3/A06/23/26 SC 13E3/ASC 13E3/A06/18/26 SC 13E3/ASC 13E3/A05/20/26